Interestingly, SCCOHTs, as well as rhabdoid tumors, depend for their survival on the EZH2 mehtyltransferase and, thus, are killed by potent and specific EZH2 inhibitors, such as tazemetostat [179]. This evidence concerns the gene EZH2 and rhabdoid tumor.